Veracyte (NASDAQ:VCYT) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS
Veracyte (NASDAQ:VCYT – Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.04, Briefing.com reports. The business had revenue of $90.32 million for the quarter, compared to the consensus estimate of $83.05 million. Veracyte had a […]